Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

This study has been completed.
Dutch Cancer Society
Information provided by (Responsible Party):
Radboud University Identifier:
First received: January 3, 2008
Last updated: November 29, 2013
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):